| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |